reviewPubMedJan 1, 2015Closed access

EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII).

AstraZeneca (Singapore) · AstraZeneca (United Kingdom)

PubMed
Indexed inpubmed

Abstract

Mutations in the epidermal growth factor receptor (EGFR) gene are commonly observed in non-small-cell lung cancer (NSCLC), particularly in tumors of adenocarcinoma (ADC) histology (NSCLC/ADC). Robust data exist regarding the prevalence of EGFR mutations in Western and Asian patients with NSCLC/ADC, yet there is a lack of data for patients of other ethnicities. This review collated available data with the aim of creating a complete, global picture of EGFR mutation frequency in patients with NSCLC/ADC by ethnicity. Worldwide literature reporting EGFR mutation frequency in patients with NSCLC/ADC was reviewed, to create a map of the world populated with EGFR mutation frequency by country (a 'global EGFR mutMap').…

Citation impact

846
total citations
FWCI
36.42
Percentile
100%
References
178
Citations per year

Authors

3

Topics & keywords

Keywords
  • Oncology
  • Adenocarcinoma
  • Lung cancer
  • Medicine
  • Epidermal growth factor receptor
  • Internal medicine
  • Mutation
  • Histology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.